284 related articles for article (PubMed ID: 33168782)
21. CD44 is a key player in non-alcoholic steatohepatitis.
Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
[TBL] [Abstract][Full Text] [Related]
22. Val-Val-Tyr-Pro protects against non-alcoholic steatohepatitis in mice by modulating the gut microbiota and gut-liver axis activation.
Xie X; Zhang L; Yuan S; Li H; Zheng C; Xie S; Sun Y; Zhang C; Wang R; Jin Y
J Cell Mol Med; 2021 Feb; 25(3):1439-1455. PubMed ID: 33400402
[TBL] [Abstract][Full Text] [Related]
23. Metabolomics-based search for therapeutic agents for non-alcoholic steatohepatitis.
Terashima Y; Nishiumi S; Minami A; Kawano Y; Hoshi N; Azuma T; Yoshida M
Arch Biochem Biophys; 2014 Aug; 555-556():55-65. PubMed ID: 24857839
[TBL] [Abstract][Full Text] [Related]
24. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.
Boursier J; Mueller O; Barret M; Machado M; Fizanne L; Araujo-Perez F; Guy CD; Seed PC; Rawls JF; David LA; Hunault G; Oberti F; Calès P; Diehl AM
Hepatology; 2016 Mar; 63(3):764-75. PubMed ID: 26600078
[TBL] [Abstract][Full Text] [Related]
25. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Ding Y; Sun X; Chen Y; Deng Y; Qian K
Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
[TBL] [Abstract][Full Text] [Related]
26. The fecal mycobiome in non-alcoholic fatty liver disease.
Demir M; Lang S; Hartmann P; Duan Y; Martin A; Miyamoto Y; Bondareva M; Zhang X; Wang Y; Kasper P; Bang C; Roderburg C; Tacke F; Steffen HM; Goeser T; Kruglov A; Eckmann L; Stärkel P; Fouts DE; Schnabl B
J Hepatol; 2022 Apr; 76(4):788-799. PubMed ID: 34896404
[TBL] [Abstract][Full Text] [Related]
27. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
Xie C; Halegoua-DeMarzio D
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752378
[TBL] [Abstract][Full Text] [Related]
28. Compact bone-derived mesenchymal stem cells attenuate nonalcoholic steatohepatitis in a mouse model by modulation of CD4 cells differentiation.
Wang H; Wang D; Yang L; Wang Y; Jia J; Na D; Chen H; Luo Y; Liu C
Int Immunopharmacol; 2017 Jan; 42():67-73. PubMed ID: 27889556
[TBL] [Abstract][Full Text] [Related]
29. β
Drescher HK; Schippers A; Clahsen T; Sahin H; Noels H; Hornef M; Wagner N; Trautwein C; Streetz KL; Kroy DC
J Hepatol; 2017 Jun; 66(6):1251-1264. PubMed ID: 28192190
[TBL] [Abstract][Full Text] [Related]
30. Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease.
Reid DT; McDonald B; Khalid T; Vo T; Schenck LP; Surette MG; Beck PL; Reimer RA; Probert CS; Rioux KP; Eksteen B
Biochim Biophys Acta; 2016 Jul; 1862(7):1337-44. PubMed ID: 27085070
[TBL] [Abstract][Full Text] [Related]
31. Gut microbiota-mediated generation of saturated fatty acids elicits inflammation in the liver in murine high-fat diet-induced steatohepatitis.
Yamada S; Kamada N; Amiya T; Nakamoto N; Nakaoka T; Kimura M; Saito Y; Ejima C; Kanai T; Saito H
BMC Gastroenterol; 2017 Nov; 17(1):136. PubMed ID: 29187142
[TBL] [Abstract][Full Text] [Related]
32. Interactions between the cecal microbiota and non-alcoholic steatohepatitis using laying hens as the model.
Hamid H; Zhang JY; Li WX; Liu C; Li ML; Zhao LH; Ji C; Ma QG
Poult Sci; 2019 Jun; 98(6):2509-2521. PubMed ID: 30690636
[TBL] [Abstract][Full Text] [Related]
33. Metabolic impact of partial hepatectomy in the non-alcoholic steatohepatitis animal model of methionine-choline deficient diet.
Carril E; Valdecantos MP; Lanzón B; Angulo S; Valverde ÁM; Godzien J; Rupérez FJ
J Pharm Biomed Anal; 2020 Jan; 178():112958. PubMed ID: 31718984
[TBL] [Abstract][Full Text] [Related]
34. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
Duan X; Meng Q; Wang C; Liu Z; Liu Q; Sun H; Sun P; Yang X; Huo X; Peng J; Liu K
Phytomedicine; 2017 Feb; 25():83-92. PubMed ID: 28190475
[TBL] [Abstract][Full Text] [Related]
35. The improvement of nonalcoholic steatohepatitis by Poria cocos polysaccharides associated with gut microbiota and NF-κB/CCL3/CCR1 axis.
Tan YY; Yue SR; Lu AP; Zhang L; Ji G; Liu BC; Wang RR
Phytomedicine; 2022 Aug; 103():154208. PubMed ID: 35691078
[TBL] [Abstract][Full Text] [Related]
36. Lycium barbarum polysaccharides improve hepatic injury through NFkappa-B and NLRP3/6 pathways in a methionine choline deficient diet steatohepatitis mouse model.
Xiao J; Wang F; Liong EC; So KF; Tipoe GL
Int J Biol Macromol; 2018 Dec; 120(Pt B):1480-1489. PubMed ID: 30266645
[TBL] [Abstract][Full Text] [Related]
37. Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid.
Yoo W; Gjuka D; Stevenson HL; Song X; Shen H; Yoo SY; Wang J; Fallon M; Ioannou GN; Harrison SA; Beretta L
PLoS One; 2017; 12(12):e0189965. PubMed ID: 29244873
[TBL] [Abstract][Full Text] [Related]
38. Dual role of protein tyrosine phosphatase 1B in the progression and reversion of non-alcoholic steatohepatitis.
González-Rodríguez Á; Valdecantos MP; Rada P; Addante A; Barahona I; Rey E; Pardo V; Ruiz L; Laiglesia LM; Moreno-Aliaga MJ; García-Monzón C; Sánchez A; Valverde ÁM
Mol Metab; 2018 Jan; 7():132-146. PubMed ID: 29126873
[TBL] [Abstract][Full Text] [Related]
39. Involvement of resistin-like molecule β in the development of methionine-choline deficient diet-induced non-alcoholic steatohepatitis in mice.
Okubo H; Kushiyama A; Sakoda H; Nakatsu Y; Iizuka M; Taki N; Fujishiro M; Fukushima T; Kamata H; Nagamachi A; Inaba T; Nishimura F; Katagiri H; Asahara T; Yoshida Y; Chonan O; Encinas J; Asano T
Sci Rep; 2016 Jan; 6():20157. PubMed ID: 26818807
[TBL] [Abstract][Full Text] [Related]
40. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
